Notice Number: NOT-DK-19-023
Key Dates
Release Date: July 17, 2019
RFA-DK-19-003
Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Purpose
The purpose of this Notice is to change the application due date and revise the multi-component application instructions for RFA-DK-19-003, "Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)". The application receipt date for RFA-DK-19-003 is now August 23, 2019. No late applications will be accepted for this Funding Opportunity Announcement.
Part I. Overview Information, Key Dates Section has been revised as follows:
Previously read:
Key Dates
Open Date (Earliest Submission Date)
June 18, 2019
Letter of Intent Due Date(s)
June 18, 2019
Application Due Date(s)
July 18, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not applicable
Scientific Merit Review
October/November 2019
Advisory Council Review
January 2020
Earliest Start Date
April 2020
Expiration Date
July 19, 2019
Modified to read (changes in italics below):
Key Dates
Open Date (Earliest Submission Date)
July 23, 2019
Letter of Intent Due Date(s)
July 23, 2019
Application Due Date(s)
August 23, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not applicable
Scientific Merit Review
November/December 2019
Advisory Council Review
January 2020
Earliest Start Date
April 2020
Expiration Date
August 24, 2019
Under Section IV. Application and Submission Information, the Instructions for the Submission of Multi-Component Applications for the Pilot and Feasibility Program have been updated to change the required components to one.
Previously read:
Instructions for the Submission of Multi-Component Applications
The following section supplements the instructions found in the SF424 (R&R) Application Guide, and should be used for preparing a multi-component application.
- Overall: Required (Minimum: 1, Maximum of 1)
- Administrative Core (with Enrichment Program): Required (Minimum: 1, Maximum of 1)
- Biomedical Research Cores: Required (Minimum: 2, Maximum: 6)
- Pilot and Feasibility Program: Required (Minimum: 2, Maximum: 4)
Modified to read:
Instructions for the Submission of Multi-Component Applications
The following section supplements the instructions found in the SF424 (R&R) Application Guide, and should be used for preparing a multi-component application.
The application should consist of the following components:
- Overall: Required (Minimum: 1, Maximum of 1)
- Administrative Core (with Enrichment Program): Required (Minimum: 1, Maximum of 1)
- Biomedical Research Cores: Required (Minimum: 2, Maximum: 6)
- Pilot and Feasibility Program: Required (Minimum: 1, Maximum of 1)
All other aspects of this Funding Opportunity Announcement remain the same.
Inquiries
Please direct all inquiries to:
Thomas L. Eggerman, M.D., Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8813
Email: [email protected]
and Human Services (HHS)
